When was ICarbonX founded?

ICarbonX was founded in 2015 and become a unicorn in its 1st funding round in 2016.

Where is ICarbonX located?

ICarbonX is headquartered in Shenzhen, China.

Who is the current CEO of ICarbonX?

Jun Wang and Naomi Keren s of ICarbonX. Jun Wang has also founded 1 company.

How many employees does ICarbonX have?

As of Sep 30, 2026, the latest employee count at ICarbonX is 65.

Is ICarbonX a funded company?

ICarbonX is a funded company, having raised a total of $366M across 5 funding rounds to date. The company's 1st funding round was a $15M Series A round, raised on Jan 21, 2016.

How much is ICarbonX worth?

The latest valuation of ICarbonX is $1B as of Jan 01, 2018.

When was the latest funding round of ICarbonX?

ICarbonX's latest funding was a $151M Series D round on Apr 20, 2021, with participation from 2 investors.

Is ICarbonX a Life Sciences Tech company?

The primary sectors of ICarbonX are Life Sciences Tech and Artificial Intelligence.

Where does ICarbonX rank among its competitors?

ICarbonX ranks 4th amongst 114 active competitors, of which 34 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was IMU Biosciences, which secured an undisclosed amount in Jun, 2026.

Who are the top competitors of ICarbonX?

ICarbonX's top competitors include Cellworks, Life Bit and IMU Biosciences. Among them, IMU Biosciences secured the most recent funding round in June, 2026.

ICarbonX - 2026 Company Profile, Team, Funding & Competitors

ICarbonX is a series D company based in Shenzhen (China), founded in 2015 by Chun Wu, Jun Wang, Hao Li and Yingrui Li. It operates as a Provider of bioinformatic platforms for health management and drug development. ICarbonX has raised $366M in funding from investors like Tencent, China Investment Corporation and China Bridge Capital, with a current valuation of $1B. The company has 114 active competitors, including 34 funded and 4 that have exited. Its top competitors include companies like Cellworks, Life Bit and IMU Biosciences.

Sectors and market segments that ICarbonX operate in

ICarbonX serves in the HealthTech, Life Sciences, Native AI market segments.The primary business model of ICarbonX are:

Company Details

iCarbonX provides a bioinformatics platform for health management and drug development. It plans to use big data and artificial intelligence to analyze omic data along with phenotypic, social, and environmental information. The analysis would be used by individuals for health management and by pharma companies for drug development. Solutions offered are Hey me, Healthtell immune response chip, and DigitalMe. Hey me is a digital health management platform that features genetic testing, sports data tracking, prediction, customized sports programs, personalized beauty products according to skin type, personalized dietary plans. DigitalMe is a health platform that tracks the health of patients suffering from chronic disease.

Website: icarbonx.com
Social
Email ID: *****@icarbonx.com, *****@icarbonx.com
Phone Number: +86 **********

Key Metrics

Founded Year

2015

Location

Shenzhen, China

Stage

Series D

Total Funding

$366M in 5 rounds

Latest Funding Round

Series D, Apr 20, 2021, $151M

Post Money Valuation

$1B as on Jan 01, 2018

Investors

Tencent & 12 more

Ranked

4^th among 114 active competitors

Employee Count

65 as on Sep 30, 2026

Investment & Acquisitions

Somalogic & 6 more

Similar Companies

OpenEvidence & 2968 more

View ICarbonX's full profile

ICarbonX has raised a total funding of $366M over 5 rounds. Its first funding round was on Jan 21, 2016. Its latest funding round was a Series D round on Apr 20, 2021 for $151M. 2 investors participated in its latest round. ICarbonX has 13 institutional investors.

Here is the list of recent funding rounds of ICarbonX:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 20, 2021	$151M	Series D	-	-	China Money Network, China Investment Corporation	-
2018	Undisclosed	Series A	$1B	-	Wealthking Investments	-
Jul 15, 2016	$45M	Series A	-	-	China Bridge Capital	-

Access funding benchmarks and valuations. Sign up today!

View details of ICarbonX's funding rounds and investors

The founders of ICarbonX are Chun Wu, Jun Wang, Hao Li and Yingrui Li. Jun Wang is the CEO of ICarbonX.

Here are the details of ICarbonX's key team members:

Chun Wu: Co-Founder & COO of ICarbonX.
Contact Info: 1 email address
Jun Wang: Co-Founder & CEO of ICarbonX.
Hao Li: Co-Founder & CIO of ICarbonX.
Yingrui Li: Co-Founder & Chief Scientist of ICarbonX.
Naomi Keren: Co-Founder and CPO of ICarbonX.

View details of ICarbonX's Founder profiles and Board Members

ICarbonX's employee count trend

ICarbonX has 65 employees as of Sep 26. Here is ICarbonX's employee count trend over the years:

Uncover ICarbonX's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ICarbonX include Cellworks, Life Bit and IMU Biosciences. Here is the list of Top 10 competitors of ICarbonX, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Cellworks 2005, San Jose (United States), Series B	Developer of a biosimulation platform	$16.5M	Bering Capital, Artiman & 3 others	66/100
2nd	Life Bit 2017, London (United Kingdom), Series B	AI and SaaS-based genomics analysis software for drug development	$70.9M	Tiger Global Management, Idinvest Partners ... & 13 others	57/100
3rd	IMU Biosciences 2019, London (United Kingdom), Series A	Provider of immune discovery platform for precision medicines	$53M	Molten Ventures, IQ Capital & 4 others	56/100
4th	ICarbonX 2015, Shenzhen (China), Series D	Provider of bioinformatic platforms for health management and drug development	$366M	Three Leaf Ventures, ScaleUp inBrazil & 11 others	55/100
5th	Biostate 2023, Houston (United States), Series A	Developer of generative AI based RNAstate research platform to predict future omics states	$16M	Accel, Catapult & 10 others	54/100
6th	NeoCura 2017, Changping (China), Series A	Provider of an AI-enabled immunotherapy based tumor diagnostic platform	$38.2M	CDH, PICC Capital Investment Management & 5 others	51/100
7th	Liquid Biosciences 2017, Aliso Viejo (United States), Series C	Provider of bio-analytics platform to identify the biological and behavioral truth driving patient outcomes	$40.1M	-	51/100
8th	Watershed 2019, Sacramento (United States), Series A	Provider of software solution for biological data analysis, discovery, and collaboration	$19.7M	Canvas Ventures, Accomplice & 3 others	48/100
9th	ROSALIND 2013, San Diego (United States), Seed	Cloud-based collaborative bioinformatics platform for researchers	$70K	Tech Coast Angels, Wavemaker 360 & 2 others	47/100
10th	Ardigen 2015, Krakow (Poland), Funding Raised	Provider of AI-driven solutions for drug discovery and clinical development	-	NCBR	44/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on ICarbonX's competitors? Click here to see the top ones

ICarbonX has made 6 investments in companies including Somalogic and Healthloop. ICarbonX has also acquired 1 companies including Imagu.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jul 26, 2018	Investments	Somalogic	1999	Boulder (United States)
May 03, 2017	Investments	Healthloop	2009	Mountain View (United States)
Jan 05, 2017	Investments	Somalogic	1999	Boulder (United States)